Can Can
Impact in
-
- Acute Myeloid Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 6
-
- Circular RNAs in diseases 3
- Mitochondrial Function and Pathology 1
- Co-authors
- Daoxin Ma (15 shared papers)Jinting Liu (8 shared papers)Chunyan Ji (4 shared papers)Ruiqing Wang (2 shared papers)Fabao Liu (1 shared paper)Xinyu Yang (1 shared paper)Wancheng Liu (9 shared papers)Xiang Hu (3 shared papers)
In The Last Decade
Can Can
15 papers receiving 292 citations
Can Can's Hit Papers
Peers
Comparison fields: 5 of 51
- Hematology 32
- Cancer Research 29
- Molecular Biology 124
- Immunology 27
- Oncology 28
Countries citing papers authored by Can Can
This map shows the geographic impact of Can Can's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Can with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Can more than expected).
Fields of papers citing papers by Can Can
This network shows the impact of papers produced by Can Can. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Can. The network helps show where Can Can may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Can, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization Hit paper breakdown → | 2022 | 124 |
| 2 | 2024 | 43 | |
| 3 | 2023 | 33 | |
| 4 | 2023 | 28 | |
| 5 | 2024 | 14 | |
| 6 | 2025 | 14 | |
| 7 | 2025 | 13 | |
| 8 | 2025 | 7 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 3 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 0 |
About Can Can
Can Can is a scholar working on Hematology, Molecular Biology, Behavioral Neuroscience, Genetics and Cancer Research, having authored 16 papers that have together received 293 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (1 paper), Mitochondrial Function and Pathology (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Ferroptosis and cancer prognosis (1 paper) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Hematology (32 citations), Cancer Research (29 citations), Molecular Biology (124 citations), Immunology (27 citations) and Oncology (28 citations). Can Can has collaborated with scholars based in China and Singapore. Frequent co-authors include Daoxin Ma, Jinting Liu, Chunyan Ji, Ruiqing Wang, Fabao Liu, Xinyu Yang, Wancheng Liu, Xiang Hu, Hanyang Wu and Xinyu Yang. Their work appears in journals such as Clinica Chimica Acta, Biomarker Research, Molecular Cancer, Translational Oncology and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.